Abstract
IntroductionHypercoagulation is one the main features of COVID-19. It is induced by the hyperinflammatory response that shifts the balance of haemostasis towards pro-coagulation. Interleukin-6 (IL-6) antagonist therapy has been recommended...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have